"당신의 실제 나이는 몇 살인가요?" 달력 나이가 아닌 몸의 생물학적 나이를 측정하려는 시도가 수십 년간 이어지고 있다. 에피제네틱 시계, 텔로미어 길이, 단백체 시계, 뇌 나이 측정까지 — 지금은 선택지가 너무 많다. 과연 어떤 것이 실제로 미래 건강을 가장 잘 예측할까?
*Communications Medicine*에 발표된 이 종합 종단 연구는 베를린 노화 연구 II(BASE-II) 참가자 1,083명(기준 시점 평균 연령 68.3세, 여성 52%)을 평균 7.4년간 추적하며 무려 16가지 생물학적 노화 지표를 동시에 비교했다. 에피제네틱 시계(Horvath, GrimAge, PhenoAge 등), 단백체 시계, 텔로미어 길이, 피부 나이(SkinAge), 복합 검사 지표(BioAge, 알로스타틱 부하), 심리적 노화, 뇌 나이까지 포함됐다.
결과는 명확했다. 알로스타틱 부하 지수(Allostatic Load Index)와 DunedinPACE가 횡단면과 종단면 분석 모두에서 가장 강하고 일관된 연관성을 보였다. 노쇠(Fried 기준), 심혈관 고위험(Life's Simple 7), 대사증후군 — 세 가지 주요 건강 결과를 예측하는 모든 모델에서 이 두 지표를 추가했을 때 예측 정확도가 최대 24%p 향상됐다.
알로스타틱 부하는 혈압, 허리둘레, 콜레스테롤, 혈당, 코르티솔 등 여러 생리 시스템의 마모도를 종합한 복합 지표다. DunedinPACE는 혈액 DNA 메틸화 패턴을 분석해 개인이 1년에 몇 살씩 노화하는지를 '속도'로 나타내는 에피제네틱 지표다. 두 지표 모두 인체 여러 시스템이 얼마나 소모되고 있는지를 통합적으로 반영한다는 공통점이 있다.
반면 전통적으로 주목받던 텔로미어 길이나 일부 에피제네틱 시계는 특정 조건에서만 유용하거나 전반적인 예측력이 제한적이었다. 이는 노화가 단일 경로가 아닌 복합적인 생리 시스템 저하임을 방증한다.
이 연구의 의의는 여러 지표를 동일 집단에서 장기간 비교함으로써 어떤 지표가 임상적으로 유용한지에 대한 근거를 제시했다는 점이다. 다만 참가자 대부분이 독일 베를린 거주 교육 수준이 높은 고령자로 구성되어 일반화에 한계가 있다.
일상에서 알로스타틱 부하를 줄이는 방법은 곧 생활 습관의 기본기와 일치한다. 혈압 관리, 체중 조절, 규칙적인 운동, 충분한 수면, 스트레스 완화 — 이 다섯 가지가 생물학적 노화 속도를 늦추는 핵심이다.
📖 *Comprehensive cross-sectional and longitudinal comparison of sixteen markers of biological aging from the Berlin Aging Study II (종단 코호트 연구, 1,083명, 7.4년 추적)* |
논문 원문
※ 이 기사는 의학 논문을 바탕으로 작성되었습니다. 개인 건강 상태에 따라 다를 수 있으니 전문의와 상담하세요.
The quest to measure how old your body truly is — regardless of what the calendar says — has spawned a proliferating industry of biological aging clocks. Epigenetic clocks that read chemical marks on DNA. Blood protein panels. Telomere length measurements. Brain age estimates from MRI scans. With so many options, a critical question has gone largely unanswered: which of these clocks actually predicts future health problems most reliably?
A rigorous seven-year longitudinal study published in *Communications Medicine* set out to answer exactly that. Using data from the Berlin Aging Study II (BASE-II), researchers tracked 1,083 older adults (mean age 68.3 at baseline, 52% women) for an average of 7.4 years and evaluated 16 different biological aging markers simultaneously — the most comprehensive head-to-head comparison of aging clocks ever conducted in a single cohort.
The Contenders
The 16 markers included multiple generations of epigenetic clocks (Horvath, GrimAge, PhenoAge, DunedinPACE, and others), a proteomics-based clock, telomere length, SkinAge, composite laboratory markers (BioAge and Allostatic Load), psychological aging indices, and brain age derived from MRI data.
Researchers examined how well each marker associated with seven health outcomes: frailty, mobility limitations, cognitive function, depressive symptoms, daily living autonomy, nutritional status, chronic disease burden, and morbidity. Both cross-sectional associations and prospective (longitudinal) predictions were evaluated.
Two Clear Winners
The results converged on a decisive finding: Allostatic Load Index and DunedinPACE stood out as the strongest and most consistent predictors of future health problems, both cross-sectionally and over the 7.4-year follow-up.
When either marker was added to logistic regression models predicting the three most clinically important outcomes — incident metabolic syndrome, high cardiovascular risk (assessed via Life's Simple 7), and incident frailty (Fried's frailty index) — prediction accuracy improved by up to 24 percentage points. No other aging marker came close to this level of consistent, multi-outcome predictive power.
Understanding the Two Winning Markers
*Allostatic Load* is a composite score of physiological wear across multiple body systems — typically including blood pressure, waist circumference, cholesterol, fasting glucose, cortisol, and inflammatory markers. It captures cumulative biological stress rather than any single pathway, which may explain its robust predictive performance across diverse health outcomes.
*DunedinPACE* is an epigenetic clock derived from DNA methylation patterns in blood, calibrated using longitudinal data from a birth cohort in New Zealand. Rather than estimating biological age in years, it measures the *rate* of aging — essentially asking: "How fast is this person's biology deteriorating?" A DunedinPACE above 1.0 means aging faster than the calendar; below 1.0 means aging more slowly.
Both markers share a conceptual thread: they measure how comprehensively the body's systems are being consumed by the aging process, rather than focusing on a single molecular pathway.
What the Other Clocks Got Wrong (Or Right in a Narrow Way)
Telomere length and several epigenetic clocks showed associations with specific outcomes but lacked the breadth and consistency of Allostatic Load and DunedinPACE. This aligns with the emerging view that aging is not a single process but a convergence of failures across multiple biological systems — and that the best aging clocks are those that capture systemic wear rather than molecular snapshots.
Limitations
The BASE-II cohort is composed primarily of well-educated, urban-dwelling older Germans, which limits generalizability. The study also relied on a single geographic and cultural context, and data collection methods for some markers evolved over the study period.
Practical Takeaways
Reducing Allostatic Load — the combined burden on your physiological systems — maps directly onto evidence-based health recommendations: controlling blood pressure and blood sugar, maintaining a healthy weight, exercising regularly, sleeping adequately, and managing chronic stress. These interventions collectively target the multi-system wear that both Allostatic Load and DunedinPACE measure, providing a coherent biological rationale for why lifestyle medicine matters at the cellular level.
📖 *Comprehensive cross-sectional and longitudinal comparison of sixteen markers of biological aging from the Berlin Aging Study II (Longitudinal cohort, n=1,083, 7.4-year follow-up)* |
Source
※ This article is based on a published medical study. Individual health circumstances vary — consult your physician before making any changes to your care.
